A Study of Erdafitinib Versus Investigator Choice of Intravesical Chemotherapy in Participants Who Received Bacillus Calmette-Guérin (BCG) and Recurred With High Risk Non-Muscle-Invasive Bladder Cancer (NMIBC)
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Institut Cancerologie de l'Ouest
UroGen Pharma Ltd.
Ferring Pharmaceuticals
NanOlogy, LLC
Corewell Health West
Viralytics
Halozyme Therapeutics
Aadi Bioscience, Inc.
Photocure
FKD Therapies Oy
Duke University
University of Rome Tor Vergata